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Abstract. 
 
Adhesion of blood leukocytes to the endo-
thelium involves multiple steps including initial attach-
ment (tethering), rolling, and firm arrest. Presentation 
of adhesion molecules on leukocyte microvilli can sub-
stantially enhance tethering. Localization of L-selectin 
to microvilli and of CD44 to the planar cell body have 
been shown to depend upon their transmembrane and 
cytoplasmic domains. We investigated the role of leu-
kocyte integrin transmembrane and cytoplasmic do-
mains in initiating adhesion under flow and in microvil-
lous localization. Integrins 
 
a
 
4
 
b
 
7, 
 
a
 
L
 
b
 
2, and 
 
a
 
M
 
b
 
2 were 
heterologously expressed in K562 cells. 
 
a
 
4
 
b
 
7 initiated 
adhesion under flow and localized to microvilli, 
whereas 
 
b
 
2 integrins did not initiate adhesion and lo-
calized to the cell body. Chimeric integrins were pro-
duced by replacing the 
 
a
 
4
 
b
 
7 cytoplasmic and/or trans-
membrane domains with the homologous domains of 
 
a
 
L
 
b
 
2 or 
 
a
 
M
 
b
 
2. Unexpectedly, these chimeras effi-
ciently mediated adhesion to the 
 
a
 
4
 
b
 
7 ligand mucosal 
addressin cell adhesion molecule–1 under flow and lo-
calized to microvilli. Therefore, differences between 
the transmembrane and cytoplasmic domains of 
 
a
 
4 and 
 
b
 
2 integrins do not account for differences in ability to 
support attachment under flow or in membrane local-
ization. Integrins 
 
a
 
4
 
b
 
1, 
 
a
 
5
 
b
 
1, 
 
a
 
6A
 
b
 
1, 
 
a
 
v
 
b
 
3, and 
 
a
 
E
 
b
 
7 
also localized to microvilli. Transmembrane proteins 
known or suspected to associate with extracellular do-
mains of microvillous integrins, including tetraspans 
and CD47, were concentrated on microvilli as well. 
These findings suggest that interactions between the 
extracellular domains of integrins and associated pro-
teins could direct the assembly of multimolecular com-
plexes on leukocyte microvilli.
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L
 
eukocyte
 
 recruitment to tissues from blood involves a
series of adhesive interactions between leukocytes
and the vascular endothelium (Springer, 1994; Butcher
and Picker, 1996). In some cases, initial binding of leuko-
cyte adhesion molecules to their endothelial ligands can
lead to the transient arrest, or tethering, of the leukocyte
followed by leukocyte rolling. Rolling cells can then be
“activated” via incompletely understood mechanisms,
which lead to an increase in the activity of certain adhe-
sion molecules and the arrest of the leukocyte on the lu-
menal surface of the endothelium. In other cases, leuko-
cytes may arrest immediately, without rolling. After arrest,
leukocytes can extravasate into the underlying tissue. Dif-
ferent leukocyte adhesion molecules are used for different
steps in this process (von Andrian et al., 1991). L-selectin
and the E- and P-selectin ligands are expressed on some
leukocytes and mediate initial adhesion (tethering and
rolling), but do not support firm arrest. In contrast, the
leukocyte 
 
b
 
2 integrins 
 
a
 
L
 
b
 
2 (LFA-1, CD11a/CD18) and
 
a
 
M
 
b
 
2 (Mac-1, CD11b/CD18) mediate firm arrest but not
initial adhesion. Another integrin subfamily, the 
 
a
 
4 inte-
grins 
 
a
 
4
 
b
 
1 (VLA-4, CD49d/CD29) and 
 
a
 
4
 
b
 
7 (LPAM-1),
can support both initial adhesion and firm arrest (Srirama-
rao et al., 1994; Alon et al., 1995; Berlin et al., 1995).
Presentation of certain leukocyte adhesion molecules on
microvilli substantially enhances the ability of these mole-
cules to support tethering and rolling on endothelial ligands.
The importance of receptor distribution was highlighted
by studies of the adhesion molecules L-selectin and CD44
(von Andrian et al., 1995). L-selectin is located primarily
on microvilli, whereas CD44 is concentrated on the planar
cell body. L-selectin–CD44 chimeras were used to exam-
ine the role of cytoplasmic and transmembrane domains in
receptor localization and the ability to roll on ligands. A
chimera comprising the L-selectin extracellular domain
fused to the CD44 transmembrane and cytoplasmic do-
mains (L/CD44) localized to the cell body, and a CD44 ex-
tracellular, L-selectin transmembrane and cytoplasmic do-
main chimera (CD44/L) localized to microvilli. Although
replacement of the transmembrane and cytoplasmic do-
mains of L-selectin or CD44 did not alter their ability to
adhere under static (no flow) conditions, it affected adhe-
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sion under flow. L-selectin (on microvilli) supported initial
attachment better than the L/CD44 chimera (cell body),
whereas CD44/L (microvilli) supported initial attachment
better than CD44 (cell body). These results indicate that
the transmembrane and/or cytoplasmic domains account
for the differences in localization of L-selectin and CD44,
and strongly suggest that microvillous localization is im-
portant for optimal initial adhesion under flow.
Available evidence about the distribution of integrins
on the leukocyte surface is also consistent with a role for
microvillous presentation in initial adhesion under flow.
Integrins 
 
a
 
L
 
b
 
2 and 
 
a
 
M
 
b
 
2 are concentrated on the planar
cell body and do not support initial adhesion, whereas
 
a
 
4
 
b
 
1 and 
 
a
 
4
 
b
 
7 localize primarily to microvilli and do sup-
port tethering and rolling (Erlandsen et al., 1993; Berlin et
al., 1995). The mechanism underlying the differential to-
pography of these integrins on nonadherent leukocytes is
not known. However, studies of other integrins have es-
tablished a central role for the cytoplasmic domains of in-
tegrin 
 
b
 
 subunits in localization of integrins on membranes
of adherent cells (LaFlamme et al., 1992, 1994; Briesewitz
et al., 1993; Sastry and Horwitz, 1993; Ylanne et al., 1993;
Pasqualini and Hemler, 1994). Interactions with several
cytoskeletal proteins such as talin and 
 
a
 
-actinin (demon-
strated in vitro) are suggestive of links to microfilament
fibers that may regulate protein localization. In addition,
several transmembrane proteins, such as tetraspan pro-
teins (including CD9, CD53, CD63, CD81, and CD82)
(Slupsky et al., 1989; Rubinstein et al., 1994; Berditchevski
et al., 1995, 1996, 1997), CD32 (Fc
 
g
 
RIIA) (Worth et al.,
1996), and CD47 (integrin-associated protein) (Lindberg
et al., 1993), have been shown to associate with integrins.
These interactions are known or suspected to involve the
extracellular domains of these proteins, and their role (if
any) in integrin localization is unknown.
We sought to examine the role of leukocyte integrin
transmembrane and cytoplasmic domains in microvillous
localization and in initial adhesion under flow. Here we re-
port that replacement of 
 
a
 
4
 
b
 
7 transmembrane and cyto-
plasmic domains with the homologous domains of 
 
b
 
2 inte-
grins does not alter membrane localization or initiation of
adhesion under flow. This unexpected result suggests that
differences in localization of leukocyte integrins to mi-
crovilli are determined by the extracellular domain.
 
Materials and Methods
 
Cell Lines
 
K562 human erythroleukemia cells (CCL 243; American Type Culture
Collection, Rockville, MD) were maintained in growth medium: RPMI
1640 supplemented with 10% FBS, penicillin (50 IU/ml), streptomycin (50
 
m
 
g/ml), and glutamine (2 mM). Stably transfected K562 lines expressing
human integrin 
 
a
 
4 (K562-
 
a
 
4
 
b
 
1) and 
 
a
 
4
 
b
 
7 (K562-
 
a
 
4
 
b
 
7) were described
previously (Tidswell et al., 1997). Additional K562 integrin transfectants
were provided by other investigators: K562-
 
a
 
L
 
b
 
2 and K562-
 
a
 
M
 
b
 
2 (I.
Graham, Washington University, St. Louis, MO) (Graham et al., 1994);
K562-
 
a
 
6A
 
b
 
1 (A. Sonnenberg, The Netherlands Cancer Institute, Amster-
dam, The Netherlands) (Hogervorst et al., 1993); K562-
 
a
 
v
 
b
 
3 (S. Blystone,
Washington University) (Blystone et al., 1994).
 
cDNAs
 
The pCDM8-integrin 
 
a
 
4 cDNA plasmid (Kamata et al., 1995) was a gift
from Y. Takada (Scripps Research Institute, La Jolla, CA). The cloning of
the 
 
b
 
7 cDNA has been previously described (Erle et al., 1991). Integrin 
 
b
 
2
cDNA (Hickstein et al., 1988) was provided by D. Hickstein (University
of Washington, Seattle, WA). Integrin 
 
a
 
L (Larson et al., 1989) and 
 
a
 
M
(Corbi et al., 1988) cDNAs were provided by T. Springer (Center for
Blood Research, Boston, MA). 
 
a
 
E cDNA (Shaw et al., 1994) was a gift
from G. Russell and M. Brenner (Harvard Medical School, Boston, MA).
Chimeric integrin subunits were constructed using splice overlap exten-
sion PCR (Horton et al., 1989). The amino acid splice sites for each con-
struct are shown in Fig. 1. Chimeric 
 
a
 
 subunits were subcloned into
pCDM8 (Invitrogen, San Diego, CA) and chimeric 
 
b
 
 subunits were sub-
cloned into pCEP4 (Invitrogen). The integrity of the constructs was con-
firmed by DNA sequencing.
 
Transfections and Expression
 
K562 cells in log phase growth were washed twice in electroporation
buffer (HBSS, 20 mM Hepes, 6 mM dextrose). 8 
 
3
 
 10
 
6
 
 cells were resus-
pended in 0.2 ml buffer and transferred to 2 mm electroporation cuvettes
(BTX, San Diego, CA). Stable transfections were performed using the
pCDM8-
 
a
 
4 and pCEP-
 
b
 
7 constructs (25 
 
m
 
g each) plus 5 
 
m
 
g pBK-neo
(Stratagene, La Jolla, CA) at 900 
 
m
 
Farad, 200 V, 13 
 
V
 
 (Electro Cell Ma-
nipulator 600; BTX). Samples were left at room temperature for 10 min
before and after electroporation. Cells were then placed in 20 ml growth
medium and maintained at 37
 
8
 
C in a 5% CO
 
2
 
 incubator. After 48 h, trans-
fectants were selected using growth medium containing 500 
 
m
 
g/ml each of
Hygromycin B (Calbiochem-Novabiochem Corp., La Jolla, CA) and G418
(GIBCO BRL, Gaithersburg, MD). Stably transfected clones were ob-
tained by limiting dilution and analyzed by flow cytometry as previously
described (Tidswell et al., 1997). Transfectants were maintained in selec-
tion medium.
 
Antibodies
 
Fib 504 (anti-integrin 
 
b
 
7) was a gift of E.C. Butcher (Stanford University,
Palo Alto, CA) (Andrew et al., 1994). HP1/2 was used to detect the inte-
grin 
 
a
 
4 subunit (Pulido et al., 1991). 7E4 (anti-
 
b
 
2) and GoH3 (anti-
 
a
 
6)
were purchased from Immunotech (Westbrook, ME). L230 (anti-
 
a
 
v) and
B11G2 (anti-
 
a
 
5) were provided by D. Sheppard and C. Damsky (University
of California, San Francisco, CA). Antibodies against the integrin-asso-
ciated proteins CD53 (clone HI29; PharMingen, San Diego, CA), CD63
(MAB1787; Chemicon International, Inc., Temecula, CA), and CD32
(clone IV.3; Medarex, East Annandale, NJ) were obtained from commer-
cial sources. The anti-CD47 antibody B6H12 was a gift from E. Brown
(Washington University). Hybridoma supernatants or purified IgG prepa-
rations were used for flow cytometry analysis and immunoelectron mi-
croscopy. Gold-conjugated secondary antibodies (6- or 12-nm particles)
were purchased from Jackson ImmunoResearch Laboratories, Inc. (West
Grove, PA).
 
Immunoelectron Microscopy
 
Transfectants were immunolabeled in suspension. Cells were prefixed for
20 min in 0.2% paraformaldehyde/PBS at 4
 
8
 
C. After washing twice with
PBS containing 10% goat serum, cells were incubated with primary anti-
body diluted in PBS containing 10% goat serum. After a 30-min incuba-
tion at 4
 
8
 
C and a wash with PBS, gold-conjugated secondary antibody in
PBS was added. Cells were incubated for 30 min at 4
 
8
 
C, washed twice with
PBS, and fixed in 0.1 M sodium cacodylate buffer, pH 7.4, with 3% glutar-
aldehyde. Before embedding, cells were rinsed in 0.1 M cacodylate buffer
and postfixed in 1% osmium tetroxide/0.1 M cacodylate buffer. After rins-
ing, cells were dehydrated through a graded series of acetone washes, and
infiltrated and embedded in Spurr’s epoxy resin (Ted Pella, Inc., Redding,
CA). Sections (70-nm thick) were stained with uranyl acetate and lead cit-
rate, and examined with a CM120 Phillips electron microscope (Philips
Electron Optics, Inc., Mahwah, NJ). 50–100 cells were examined and rep-
resentative cells were photographed. Each experiment was repeated at
least twice. Colloidal gold distribution on immunolabeled cells was deter-
mined by analysis of electron micrographs (
 
3
 
19,500–
 
3
 
40,000). Gold par-
ticles associated with cell body or microvilli were counted from 3–11 mi-
crographs that represented different individual cells.
 
Static Adhesion Assay
 
Static adhesion assays were performed as previously described (Tidswell
et al., 1997). Briefly, 21-well glass slides (Structure Probe, West Chester,
PA) were coated with mucosal addressin cell adhesion molecule–1 (MAd- 
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CAM–1)
 
1
 
–IgG fusion protein (4 ng/well) or intercellular adhesion mole-
cule–1 (ICAM-1)–C
 
k
 
 fusion protein (0.23 
 
m
 
g/well) overnight at 4
 
8
 
C.
MAdCAM-1–IgG (Tidswell et al., 1997) was a gift of M. Briskin (Leuko-
site Inc., Boston, MA). ICAM-1–C
 
k
 
 (Piali et al., 1995) was a gift of B. Im-
hof (Centre Medicale Universitaire, Geneva, Switzerland). After blocking
with 4% BSA for 2 h, 4 
 
3
 
 10
 
4
 
 cells were resuspended in 15 
 
m
 
l of 10 mM
Hepes, 150 mM NaCl, 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, with or without 1 mM
MnCl
 
2
 
, and added to the wells. Cells were allowed to adhere for 90 min at
room temperature. After washing, cells were fixed with 3% glutaralde-
hyde and stained with 0.5% crystal violet. Adherent cells were counted us-
ing a microscope. Assays were performed in triplicate.
 
Adhesion under Flow
 
Capillary tubes (100-
 
m
 
l capacity; Drummond, Broomall, PA) were coated
at 4
 
8
 
C overnight with 20 
 
m
 
l of solution containing MAdCAM-IgG (0.2 
 
m
 
g/
ml) or ICAM-1–Ck (0.7 mg/ml) and blocked with 4% BSA for 2 h at 378C.
K562 transfectants were washed with HBSS containing 1 mM EDTA, and
resuspended at 5 3 105 cells/ml in HBSS/10 mM Hepes containing 1 mM
each of Ca21 and Mg21. To measure adhesion under flow, cells were perfused
through the coated capillary tube using a syringe pump (74900 series;
Cole-Parmer Instrument Co., Vernon Hills, IL) at a flow rate of 0.67 ml/
min. Calculated shear stress was 1.0 dyne/cm2 according to Pousille’s law
of dynamic shear (Berlin et al., 1995). Results were captured using a TMS
microscope (Nikon, Garden City, NJ), CCD video camera (Sony, Park
Ridge, NJ), and time lapse SVMS videocassette recorder (Panasonic, Se-
caucus, NJ). After 2 min of flow, five randomly chosen fields from the
coated region were analyzed for 5 s each. All adherent cells (rolling or ar-
rested) were counted. Cells did not adhere to areas coated with 4% BSA
alone (control).
Results
Generation of Transfectants Expressing Chimeric and 
Mutant a4b7 Constructs
To examine the role of cytoplasmic and transmembrane
domains of a4b7 in adhesion and membrane localization,
we expressed chimeric integrin heterodimers (Fig. 1).
Each construct included the extracellular domains of a4
and b7. In one construct, designated a4b7(aLb2c), most
of the cytoplasmic domains of a4 and b7 were replaced
with homologous regions of aL and b2. In a second con-
struct, a4b7(aMb2tc), all of the transmembrane and cyto-
plasmic domains of a4 and b7 were replaced with homolo-
gous domains of aM and b2. The integrin a and b subunit
cDNAs were cotransfected into K562 human erythroleu-
kemia cells, which do not normally express a4, aL, aM, b2,
or b7. The levels of protein expression on the transfectants
K562-a4b7, K562-a4b7(aLb2c), and K562-a4b7(aMb2tc)
were determined to be similar by flow cytometry (Fig. 2,
A–C). Two truncated cDNAs, a4D (truncated after amino
acids GFFKR) and b7D (truncated after amino acids
VLAYR), were also produced. The a4D was expressed in
combination with b7 on transfected K562 cells (K562-a4Db7),
although at levels somewhat below those seen with other
constructs (data not shown). We were unable to detect ex-
pression of b7D on cells cotransfected with a4, despite a
previous report that the homologous truncation mutant of
mouse b7 was expressed on transfected cells (Crowe et al.,
1994). We were able to document heterologous expression
of other wild-type integrins, including aLb2, aMb2, a6Ab1,
avb3, and aEb7, on appropriate K562 transfectants by
flow cytometry (Fig. 2, D–H).
Adhesion of Transfectants to MAdCAM-1 under
Static Conditions
We analyzed the ability of integrin-transfected K562 cells
to adhere to MAdCAM-1, an a4b7 ligand, and ICAM-1,
an aLb2 ligand, under static (no flow) conditions (Fig. 3).
After transfection with a4 cDNA alone, K562 cells express
a4b1 but not a4b7 (Tidswell et al., 1997). These cells
failed to adhere to MAdCAM-1. In contrast, cells trans-
fected with both a4 and b7 (K562-a4b7) adhered effi-
ciently to MAdCAM-1. As previously reported, adhesion
was increased in the presence of Mn21. The chimeric trans-
fectants, K562-a4b7(aLb2c) and K562-a4b7(aMb2tc), also
adhered to MAdCAM-1, and the extent of adhesion was
very similar for chimeric and wild-type a4b7 transfectants.
As expected, K562-a4b7 cells did not adhere to ICAM-1,
whereas K562-aLb2 cells did.
Adhesion of Transfectants to MAdCAM-1 under Flow
We next examined the ability of the wild-type and chi-
meric integrins to initiate adhesion under flow (Fig. 4).
K562-a4b7 cells adhered to MAdCAM-1 under flow. This
adhesion was dependent upon both a4b7 and MAdCAM-1
because K562 cells transfected with a4 alone (K562-a4b1)
did not adhere to MAdCAM-1, and K562-a4b7 cells did
not adhere to capillary tubes coated with other ligands,
such as ICAM-1. The chimeric integrins, a4b7(aLb2c) and
a4b7 (aMb2tc), both supported adhesion to MAdCAM-1
under flow. Wild-type a4b7 and the chimeric integrins
were very similar in their ability to initiate adhesion under
flow. We also examined the resistance to detachment from
MAdCAM-1 at increasing shear stress conditions (up to
10 dynes/cm2). We did not find differences between wild-
type and chimeric transfectants in this assay (data not
shown). At a shear stress of 1 dyne/cm2, most cells re-
mained adherent during the time interval of cell counts.
Transfectants expressing a truncated a4 subunit (K562-
a4Db7) also adhered to MAdCAM-1 under flow, although
at a somewhat lower rate (perhaps related to lower levels
1. Abbreviations used in this paper: ICAM-1, intercellular adhesion mole-
cule–1; MAdCAM-1, mucosal addressin cell adhesion molecule–1;
VCAM-1, vascular cell adhesion molecule–1.
Figure 1. Schematic representation of wild-type and chimeric
a4b7 integrins. The amino acid sequence at the splice site is shown
with conserved regions in bold, and the aLb2 or aMb2 sequences
underlined.The Journal of Cell Biology, Volume 139, 1997 566
of expression of this construct, data not shown). As ex-
pected from previous reports (von Andrian et al., 1991),
K562-aLb2 cells were unable to initiate adhesion to their
ligand, ICAM-1, under flow (Fig. 4).
Membrane Localization of Wild-type and
Chimeric a4b7, aLb2, and aMb2 Integrins on 
Transfected K562 Cells
Previous reports demonstrated that integrin a4b7 localizes
primarily to microvilli of mouse TK-1 lymphoma cells,
whereas integrins aLb2 and aMb2 localize primarily to
the cell body of TK-1 cells and human neutrophils respec-
tively (Erlandsen et al., 1993; Berlin et al., 1995). We be-
gan by using immunoelectron microscopy to determine
whether these integrins would localize similarly in trans-
fected K562 cells. K562 cells had numerous microvillous
projections. a4b7 was found primarily on microvilli (Fig. 5 A).
In contrast, aLb2 and aMb2 integrins were located prima-
rily on the cell body (Fig. 5, B–D). Both a4b7(aLb2c) and
a4b7(aMb2tc) localized to microvillous projections (Fig.
5, E and F). A quantitative analysis of the distributions of
these integrins is shown in Table I. The a4Db7 construct
was also concentrated on microvilli (not shown). These re-
sults indicate that the transmembrane and cytoplasmic do-
mains are not responsible for the differential localization
of a4b7 versus aLb2 and aMb2.
Presentation of Other Leukocyte Integrins on Microvilli
In addition to a4b7, aLb2, and aMb2, leukocytes express
other integrins that play roles in adhesion to endothelial
cells, to other cells, and to extracellular matrix proteins.
One of these, a4b1, can initiate adhesion to vascular cell
adhesion molecule–1 (VCAM-1) under flow and has been
reported to be expressed on lymphocyte microvilli (Alon
et al., 1995; Berlin et al., 1995). We confirmed that a4b1
was also expressed preferentially on microvilli of K562-
a4b1 transfectants (Table I). We found that the T cell inte-
grin aEb7 (Cepek et al., 1994), which can mediate adhesion
to epithelium but has no established role in endothelial ad-
hesion, was also localized to microvilli of K562-aEb7 cells
(Fig. 6 A, and Table I). Integrin a6Ab1, a laminin receptor
which is expressed on monocytes and some lymphocytes,
was concentrated on microvilli of K562 transfectants (Fig.
6 B, and Table I). The vitronectin receptor, integrin avb3,
is also a receptor for the endothelial cell ligand platelet/en-
dothelial cell adhesion molecule–1 (Piali et al., 1995) and
is expressed on monocytes and other cells. We found that
avb3 localized predominantly to microvilli (Fig. 6 C, and
Table I). The fibronectin receptor, integrin a5b1, is consti-
tutively expressed on K562 cells and was also expressed
predominantly on microvilli (not shown).
Figure 2. Cell surface expression of wild-type and chimeric inte-
grins. K562-a4b7 (A), K562-a4b7 (aLb2c) (B), and K562-a4b7
(aMb2tc) (C) cells were stained with the anti-b7 antibody, Fib
504, as shown. Each of these three transfectants was also recog-
nized by other antibodies specific for the a4 subunit or the a4b7
heterodimer, but were not recognized by anti-aE antibodies (not
shown). K562-aLb2 were recognized by antibodies to b2 (D) and
aL (not shown). K562-aMb2 cells were recognized by antibodies
to b2 (E) and aM (not shown). K562-aEb7 cells stained with an-
tibodies to b7 (F) and aE, but not with anti-a4 antibodies (not
shown). K562-a6Ab1 cells were stained with the anti-a6 antibody
GoH3 (G). There was low level expression of av on nontrans-
fected K562 cells, and higher expression on K562-avb3 cells as
determined using the anti-av antibody L230 (H). Fluorescence
intensity is shown on a log scale (one log per division). Dotted
and solid histograms represent staining with nontransfected and
transfected K562 cells, respectively.
Figure 3. Static adhesion of
transfectants to immobilized
ligands. Adhesion of various
integrin transfectants to
MAdCAM-1 (top) and ICAM-1
(bottom) was measured in
the presence and absence of
Mn21. Bars indicate SEM.
nd, not determined.
Figure 4. Adhesion to ligands
under flow. Adhesion of vari-
ous integrin transfectants to
MAdCAM-1 (top) and ICAM-1
(bottom) measured at a wall
shear stress of 1 dyne/cm2 in
the absence of Mn21, as de-
scribed in Materials and
Methods. Bars indicate SEM.Abitorabi et al. Integrins on Leukocyte Microvilli 567
Localization of Transmembrane Proteins Known to 
Associate with Integrins
Integrins have been shown to associate with a variety of
intracellular and transmembrane proteins. Some of these
interactions occur within the cell and are mediated by inte-
grin cytoplasmic domains, whereas others are known or
suspected to be extracellular. Since our results suggested
that extracellular (and not transmembrane or cytoplasmic)
domains determine integrin localization, we performed
immunoelectron microscopy to localize several cell surface
proteins known or suspected to interact with integrin ex-
tracellular domains. Several members of the tetraspan
family of transmembrane proteins have been shown to as-
sociate with a4b1, a4b7, a6b1, and some other integrins
(Berditchevski et al., 1996; Mannion et al., 1996). These
associations are likely to involve the extracellular domains
of tetraspans and integrins (see Discussion). Several tet-
raspans are constitutively expressed on K562 cells. CD53
(82 6 5% on microvilli, Fig. 7 A), CD63 (92 6 4% on mi-
crovilli, Fig. 7 B), and CD81 and CD82 (data not shown)
are all localized predominantly to microvilli. Another trans-
membrane protein, CD47 (integrin-associated protein),
has been shown to associate with avb3 via its extracellular
domain. CD47, like avb3, was distributed mostly on mi-
crovilli (Fig. 7 C). CD32 is a transmembrane protein that
has been reported to associate with aMb2 (which is on the
cell body; Fig. 5 C) and possibly with the tetraspan CD82
(found on microvilli, see above) (Lebel-Binay et al., 1995).
CD32 was expressed on both microvilli (62 6 15%) and
the cell body (38 6 15%) (Fig. 7 D).
Discussion
In this study, we examined the role of leukocyte integrin
cytoplasmic and transmembrane domains in adhesion un-
der flow and microvillous localization. We began by con-
firming that previously described differences in leukocyte
integrin adhesive activity and membrane localization were
also seen in K562 cell integrin transfectants. As expected,
a4b7 was able to initiate adhesion under flow and localized
Figure 5. Localization of
a4b7,  aLb2,  aMb2, and chi-
meric integrins by immuno-
electron microscopy. K562
transfectants were stained
for protein expression using
12-nm gold particles (arrows)
as described in Materials and
Methods. Wild-type a4b7
(identified using the anti-b7
antibody, Fib 504) was local-
ized predominantly to mi-
crovilli of K562-a4b7 tran-
fectants (A). K562-aLb2 (B
and C) and K562-aMb2 (D)
were stained with antibodies
to aL (B) or b2 (C and D),
demonstrating that aLb2 and
aMb2 were expressed mostly
on the cell body. K562 cells
transfected with the chimeric
integrins  a4b7(aLb2c) (E)
and  a4b7(aMb2tc) (F) were
stained with Fib 504. These
chimeric integrins were found
predominantly on microvilli.
Photomicrographs are repre-
sentative of integrin distribu-
tion on the 50–100 cells ex-
amined in each sample. Bar,
0.5 mm.The Journal of Cell Biology, Volume 139, 1997 568
to microvilli, whereas aLb2 and aMb2 mediated adhesion
only under static conditions and localized to the planar cell
body. Two chimeras, a4b7(aLb2c) and a4b7(aMb2tc),
were expressed to examine the roles of the extracellular,
transmembrane, and cytoplasmic domains in adhesion and
membrane localization. Both chimeras were as efficient in
initiating adhesion under flow as the wild-type integrin
a4b7. The chimeras were found predominantly on mi-
crovilli, indicating that the extracellular domain (and not
the transmembrane or cytoplasmic domains) determined
membrane localization of a4b7. We have so far been un-
able to determine whether b2 integrin localization to the
cell body is also independent of the transmembrane and
cytoplasmic domains. We attempted to address this issue
by expressing a chimeric integrin composed of the extra-
cellular domain of aMb2 and the transmembrane and cy-
toplasmic domains of a4b7, but have not yet been success-
ful in these experiments. In addition to a4b7, several other
integrins (a4b1, a5b1, a6Ab1, avb3, and aEb7) were lo-
calized to microvilli. Transmembrane proteins known or
suspected to interact with integrin extracellular domains,
including tetraspan family members and CD47, were also
found to be concentrated on microvilli.
The ability of leukocyte adhesion molecules to support
initial adhesion under flow is influenced by several factors
including affinity, avidity, and accessibility to endothelial
ligands. Previous studies of nonintegrin adhesion mole-
cules indicate that cytoplasmic domains can have dramatic
effects upon initiating adhesion under flow without alter-
ing static adhesion. Experiments involving the use of L-selec-
tin–CD44 chimeras suggest that cytoplasmic domains may
influence adhesion under flow by targeting these receptors
to the microvillous or cell body (see Introduction). How-
ever, it is clear that the cytoplasmic domain of L-selectin
also has effects on initiation of adhesion that are indepen-
dent of receptor positioning. A truncation mutant of L-selec-
tin lacking the 11 COOH-terminal amino acid residues of
the cytoplasmic domain was localized to microvilli and re-
tained the ability to bind ligand, but was unable to support
rolling on endothelium (Kansas et al., 1993; Pavalko et al.,
1995). This mutant lost the ability to associate with the cy-
toskeletal proteins a-actinin and vinculin, suggesting that
interactions between adhesion molecule cytoplasmic do-
mains and cytoskeletal proteins can be important in regu-
lation of initial adhesive interactions under flow. We
Table I. Integrin Distribution on Transfected K562 Cells
Integrin Percent on microvilli Percent on body Gold particles counted
a4b7 89 6 9 11 6 9 1,288
a4b1 81 6 7 19 6 7 348
aLb2 31 6 14 69 6 14 99
aMb2 22 6 13 78 6 13 236
a4b7(aLb2c) 90 6 9 10 6 9 260
a4b7(aMb2tc) 87 6 6 13 6 6 386
aEb7 83 6 6 17 6 6 149
a6b1 77 6 9 23 6 9 401
avb3 80 6 10 20 6 10 2,741
Transfected K562 cells expressing various integrins were analyzed by immunoelec-
tron microscopy after staining with appropriate anti-integrin antibodies. For each inte-
grin, all gold particles in at least three photomicrographs were counted. Percentages
are presented as mean 6 SD.
Figure 6. Localization of aEb7, a6Ab1, and avb3 integrins by
immunoelectron microscopy. K562 transfectants were stained for
protein expression using 12-nm gold particles (arrows) as de-
scribed in Materials and Methods. Staining of K562-aEb7 with
Fib 504 (anti-b7, A), K562-a6Ab1 with anti-a6 (GoH3, B), and
K562-avb3 with L230 (anti-av, C) revealed that each of these in-
tegrins was found primarily on microvilli. Bar, 0.5 mm.Abitorabi et al. Integrins on Leukocyte Microvilli 569
found that replacement of the cytoplasmic and/or trans-
membrane domains of a4b7 (which does support adhesion
under flow) with the homologous domains of aLb2 or
aMb2 (which do not) did not affect adhesion to the a4b7
ligand MAdCAM-1 under either static or flow conditions.
This indicates that the cytoplasmic domains cannot ac-
count for the differences in ability of these integrins to
support adhesion under flow. We also found that trunca-
tion of the a4 subunit after the conserved GFFKR motif
had little if any effect on initiation of a4b7-mediated adhe-
sion to MAdCAM-1. Others have previously shown that
the same truncation of a4 did not affect the ability of a4b1
to initiate adhesion to its ligand, VCAM-1 (Kassner et al.,
1995). The a4 truncation was reported to decrease the
cell’s resistance to detachment from VCAM-1 in the face
of increasing shear force, suggesting that the a subunit cy-
toplasmic domain plays a role in strengthening adhesion.
We were unable to detect any difference in resistance to
detachment between wild-type and chimeric a4b7 inte-
grins, suggesting that a4b7, aLb2, and aMb2 integrin cy-
toplasmic domains are similar in their ability to mediate
adhesion strengthening.
Many of the adhesion molecules that initiate adhesion
to endothelium under flow are concentrated on leukocyte
microvilli.These include L-selectin (Picker et al., 1991; Er-
landsen et al., 1993; Pavalko et al., 1995), P-selectin glyco-
protein ligand–1 (Moore et al., 1995; Bruehl et al., 1997),
and the integrins a4b7 and a4b1 (Berlin et al., 1995; and
this report). Other adhesion molecules, including CD44
and the integrins aLb2 and aMb2, are found predomi-
Figure 7. Localization of in-
tegrin-associated proteins by
immunoelectron microscopy.
The tetraspan proteins CD53
(A) and CD63 (B), the avb3-
associated protein CD47 (C),
and CD32 (D) were localized
by immunoelectron micros-
copy using 12-nm (A, C, and
D) or 6-nm (B) gold particles
(arrows). The tetraspan pro-
teins and CD47 localized pri-
marily to microvilli, whereas
CD32 was found in substan-
tial amounts on both the cell
body and microvilli. Non-
transfected K562 cells (A)
and K562-a4b7 (B), K562-
aVb3 (C), and K562-aMb2
(D) transfectants were used
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nantly on the cell body (Erlandsen et al., 1993; Berlin et
al., 1995; von Andrian et al., 1995; and this report). Little
information is available about the mechanisms that lead to
the selective display of certain adhesion molecules on mi-
crovilli. It seems likely that interactions between the cyto-
plasmic domains of adhesion molecules and specific cy-
toskeletal elements can play an important role. In support
of this concept, the localization of L-selectin–CD44 chime-
ras was shown to be determined by the cytoplasmic and/or
transmembrane domains, and not by the extracellular do-
mains (see Introduction). Concentration of integrins in
other structures, such as focal adhesions and hemidesmo-
somes, is known to depend upon the b subunit cytoplasmic
domain. We were surprised to find that our analysis of in-
tegrin chimeras did not demonstrate a role for the cyto-
plasmic or transmembrane domains of either the a or b
subunit in determining membrane localization. Replace-
ment of the a4b7 cytoplasmic and/or transmembrane do-
mains with homologous domains of aLb2 or aMb2 did not
interfere with microvillous localization. Put another way,
replacement of the extracellular domain of the aLb2 or
aMb2 integrins with the extracellular domain of a4b7 re-
sulted in a shift from cell body to microvillous localization.
These results indicate an important role for the extracellu-
lar domain in directing localization of integrins to the mi-
crovillous versus the cell body.
Integrin extracellular domains can interact with other cell
surface proteins. For example, the transmembrane protein
CD47 interacts with avb3 and this interaction depends
upon the extracellular domain of CD47 (Lindberg et al.,
1996). Several members of the tetraspan family of trans-
membrane proteins, including CD53, CD63, CD81, and
CD82, have been shown to coprecipitate with some inte-
grins, including a4b1, a6b1, and a4b7, but not with aLb2
or some other integrins (Berditchevski et al., 1996; Man-
nion et al., 1996). These interactions are likely to involve
the integrin extracellular domain, since mutations of the
a4 subunit extracellular domain substantially reduce asso-
ciation whereas alterations of the a subunit cytoplasmic
domain have no effect. We found that CD47, CD53, CD63,
CD81, and CD82, all known to associate with integrins
that we localized to microvilli, were themselves concentrated
on microvilli. Our data are consistent with the hypothesis
that interactions with tetraspans and CD47 help target cer-
tain integrins to microvilli. The widespread expression of
tetraspans and CD47 on leukocytes and other cells makes
this hypothesis difficult to test directly. At least one inte-
grin that we localized to microvilli, a5b1, apparently does
not associate with tetraspans or CD47, suggesting that
other interactions also are important (Berditchevski et al.,
1996). This hypothesis assumes that a4b7 and other mi-
crovillous integrins are actively concentrated on microvilli,
but aLb2 and aMb2 are not. An alternative explanation of
our results is that microvillous expression is the “default
pathway” for integrins, and that the extracellular domains
of aLb2 and aMb2 prevent these integrins from being dis-
played on microvilli. This could be mediated by interac-
tions between b2 integrins and associated cell surface pro-
teins. Although aMb2 has been shown to associate with
CD32, the pattern of expression of CD32 (on both cell
body and microvilli) suggests that this interaction is not re-
sponsible for the concentration of aMb2 on the cell body.
We found that many integrins and integrin-associated
proteins were preferentially expressed on microvilli. Some
of these integrins, including a4b7 and a4b1, play impor-
tant roles in mediating leukocyte adhesion under flow.
Other microvillous integrins, such as a5b1 and aEb7, me-
diate adhesion to extracellular matrix proteins or epithe-
lial cells, but have no known role in initiating leukocyte–
endothelial interactions. This suggests that the assembly of
multimolecular complexes containing integrins and inte-
grin-associated proteins on microvilli may have other im-
portant roles in adhesion and signaling.
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